01Strategy 02Leadership 03Investors 04News 05Contact

CSE: ADPT

News

Adaptogenics Announces Strategy to Build Proprietary Peptide Assets and Delivery Technologies

OCT 19, 2026

View on newswire

Adaptogenics

Adaptogenics Health Corp.
CSE: ADPT

Suite 1100
1111 Melville Street
Vancouver, British Columbia
V6E 3V6
Canada

[email protected]

© 2026 Adaptogenics Health Corp.

This website contains forward looking statements about strategic objectives and potential opportunities. Actual results may differ materially. Adaptogenics has no products approved by the FDA or any other regulator, and nothing on this site claims human efficacy for any program. Descriptions of third party research and approvals are provided for context only.